FDG uptake in cancer: a continuing debate

Theranostics. 2020 Feb 6;10(7):2944-2948. doi: 10.7150/thno.40599. eCollection 2020.

Authors

Silvia Peppicelli¹, Elena Andreucci¹, Jessica Ruzzolini¹, Francesca Bianchini^{1

2}, Lido Calorini^{1

3}

Affiliations

¹ Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Section of Experimental Pathology and Oncology.
² Interdepartmental Center for Molecular Preclinical Imaging Experimentation CISPIM, University of Florence.
³ Center of Excellence for Research, Transfer and High Education DenoTHE University of Florence, Florence, Italy.

No abstract available

Publication types

Editorial

MeSH terms

Cell Line
Drug Resistance, Neoplasm
Fluorodeoxyglucose F18 / adverse effects*
Glycolysis
Humans
Neoplasms* / diagnostic imaging
Neoplasms* / therapy
Oxygen / metabolism
Positron-Emission Tomography / adverse effects*
Radiopharmaceuticals / adverse effects*
Tumor Microenvironment
Warburg Effect, Oncologic / radiation effects

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18
Oxygen